FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129126914> ?p ?o ?g. }

• W3129126914 endingPage "1535" @default.
• W3129126914 startingPage "1535" @default.
• W3129126914 abstract "Psoriasis is a chronic autoimmune skin disease impacting the population globally. Pharmaceutical products developed to combat this condition commonly used in clinical settings are IV bolus or oral drug delivery routes. There are some major challenges for effectively developing new dosage forms for topical use: API physicochemical nature, the severity of the disease state, and low bioavailability present challenges for pharmaceutical product developers. For non-severe cases of psoriasis, topical drug delivery systems may be preferred or used in conjunction with oral or parenteral therapy to address local symptoms. Elastic vesicular systems, termed “niosomes”, are promising drug delivery vehicles developed to achieve improved drug delivery into biological membranes. This study aimed to effectively incorporate a corticosteroid into the niosomes for improving the drug bioavailability of desoximetasone, used to treat skin conditions via topical delivery. Niosomes characterization measurements were drug content, pH, spreadability, specific gravity, content uniformity, rheology, and physicochemical properties. Formulations used a topical gelling agent, Carbomer 980 to test for in vitro skin permeation testing (IVPT) and accelerated stability studies. The developed niosomal test gel provided approximately 93.03 ± 0.23% to 101.84 ± 0.11% drug content with yield stresses ranging from 16.12 to 225.54 Pa. The permeated amount of desoximetasone from the niosomal gel after 24 h was 9.75 ± 0.44 µg/cm2 compared to 24.22 ± 4.29 µg/cm2 released from the reference gel tested. Furthermore, a drug retention study compared the test gel to a reference gel, demonstrating that the skin retained 30.88 ng/mg of desoximetasone while the reference product retained 26.01 ng/mg. A controlled drug release profile was obtained with a niosomal formulation containing desoximetasone for use in a topical gel formulation showing promise for potential use to treat skin diseases like psoriasis." @default.
• W3129126914 created "2021-02-15" @default.
• W3129126914 creator A5004040279 @default.
• W3129126914 creator A5033177588 @default.
• W3129126914 creator A5045452149 @default.
• W3129126914 creator A5077527392 @default.
• W3129126914 creator A5087000896 @default.
• W3129126914 date "2021-02-03" @default.
• W3129126914 modified "2023-10-18" @default.
• W3129126914 title "Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone" @default.
• W3129126914 cites W1560654611 @default.
• W3129126914 cites W1794483082 @default.
• W3129126914 cites W1964487329 @default.
• W3129126914 cites W1966214888 @default.
• W3129126914 cites W1970416499 @default.
• W3129126914 cites W1974056632 @default.
• W3129126914 cites W1993372427 @default.
• W3129126914 cites W2000305237 @default.
• W3129126914 cites W2009841111 @default.
• W3129126914 cites W2013500776 @default.
• W3129126914 cites W2014298286 @default.
• W3129126914 cites W2027457627 @default.
• W3129126914 cites W2028052095 @default.
• W3129126914 cites W2037304347 @default.
• W3129126914 cites W2041606511 @default.
• W3129126914 cites W2045316892 @default.
• W3129126914 cites W2060370203 @default.
• W3129126914 cites W2074817486 @default.
• W3129126914 cites W2079025207 @default.
• W3129126914 cites W2082724339 @default.
• W3129126914 cites W2086130473 @default.
• W3129126914 cites W2086636457 @default.
• W3129126914 cites W2088641997 @default.
• W3129126914 cites W2110518646 @default.
• W3129126914 cites W2127083053 @default.
• W3129126914 cites W2128357711 @default.
• W3129126914 cites W2160096806 @default.
• W3129126914 cites W2161617966 @default.
• W3129126914 cites W2162559968 @default.
• W3129126914 cites W2166408663 @default.
• W3129126914 cites W2332568113 @default.
• W3129126914 cites W2345688875 @default.
• W3129126914 cites W2420409461 @default.
• W3129126914 cites W2424671968 @default.
• W3129126914 cites W2469892682 @default.
• W3129126914 cites W2566666513 @default.
• W3129126914 cites W2802168142 @default.
• W3129126914 cites W2988464445 @default.
• W3129126914 cites W3010327875 @default.
• W3129126914 cites W3014844306 @default.
• W3129126914 doi "https://doi.org/10.3390/ijms22041535" @default.
• W3129126914 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7913730" @default.
• W3129126914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33546426" @default.
• W3129126914 hasPublicationYear "2021" @default.
• W3129126914 type Work @default.
• W3129126914 sameAs 3129126914 @default.
• W3129126914 citedByCount "11" @default.
• W3129126914 countsByYear W31291269142021 @default.
• W3129126914 countsByYear W31291269142022 @default.
• W3129126914 countsByYear W31291269142023 @default.
• W3129126914 crossrefType "journal-article" @default.
• W3129126914 hasAuthorship W3129126914A5004040279 @default.
• W3129126914 hasAuthorship W3129126914A5033177588 @default.
• W3129126914 hasAuthorship W3129126914A5045452149 @default.
• W3129126914 hasAuthorship W3129126914A5077527392 @default.
• W3129126914 hasAuthorship W3129126914A5087000896 @default.
• W3129126914 hasBestOaLocation W31291269141 @default.
• W3129126914 hasConcept C130316041 @default.
• W3129126914 hasConcept C16005928 @default.
• W3129126914 hasConcept C171250308 @default.
• W3129126914 hasConcept C181389837 @default.
• W3129126914 hasConcept C185592680 @default.
• W3129126914 hasConcept C192562407 @default.
• W3129126914 hasConcept C2779820397 @default.
• W3129126914 hasConcept C2780035454 @default.
• W3129126914 hasConcept C2780564577 @default.
• W3129126914 hasConcept C41625074 @default.
• W3129126914 hasConcept C43617362 @default.
• W3129126914 hasConcept C45904493 @default.
• W3129126914 hasConcept C50670333 @default.
• W3129126914 hasConcept C55493867 @default.
• W3129126914 hasConcept C58226133 @default.
• W3129126914 hasConcept C71924100 @default.
• W3129126914 hasConcept C72918618 @default.
• W3129126914 hasConcept C77281830 @default.
• W3129126914 hasConcept C98274493 @default.
• W3129126914 hasConceptScore W3129126914C130316041 @default.
• W3129126914 hasConceptScore W3129126914C16005928 @default.
• W3129126914 hasConceptScore W3129126914C171250308 @default.
• W3129126914 hasConceptScore W3129126914C181389837 @default.
• W3129126914 hasConceptScore W3129126914C185592680 @default.
• W3129126914 hasConceptScore W3129126914C192562407 @default.
• W3129126914 hasConceptScore W3129126914C2779820397 @default.
• W3129126914 hasConceptScore W3129126914C2780035454 @default.
• W3129126914 hasConceptScore W3129126914C2780564577 @default.
• W3129126914 hasConceptScore W3129126914C41625074 @default.
• W3129126914 hasConceptScore W3129126914C43617362 @default.
• W3129126914 hasConceptScore W3129126914C45904493 @default.

• next